| FDA committee recommends new drug applications for ezetimibe, simvastatin - Cardiology Today |
|
|
Cardiology Today The FDA's Endocrinologic and Metabolic Drugs Advisory Committee today recommended approval of the new drug application for ezetimibe/simvastatin for the prevention of major vascular events in patients with pre-dialysis chronic kidney disease, |